Nomax Recalls Subpotent Dry Eye Test Fluorescein Sodium Strips
Nomax Inc. is voluntarily recalling 78 cartons of Dry Eye Test strips due to subpotent drug content. The FDA classified this as a Class III recall.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Nomax Inc. is voluntarily recalling 78 cartons of Dry Eye Test (Fluorescein Sodium) Ophthalmic Strips. The product is identified by NDC 51801-008-15, Lot 13336, and an expiration date of 07/23. Each carton contains 100 sterile strips packaged in 50 pouches of 2 strips each.
The recall was initiated because the product was found to be a subpotent drug, meaning it did not contain the full amount of the active ingredient as labeled. The FDA classified this recall as Class III, which indicates that use of or exposure to the violative product is not likely to cause adverse health consequences.
The affected product was distributed nationwide in the United States. The recall was initiated on April 13, 2021, and was terminated on September 28, 2023. Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above.
The recalled product
- Product
- DRY EYE TEST (FLUORESCEIN SODIUM)
- Brand
- DRY EYE TEST
- Manufacturer
- Nomax Inc
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 78
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- LOT 13336 EXP 07/23
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Nomax Inc
See all →- ModerateFUL-GLO Fluorescein Sodium Ophthalmic Strips Recalled for API Manufacturing Defect
FDA (Drugs) · 2024-05-01
- HighGloStrips ophthalmic drug recalled for active ingredient impurities
FDA (Drugs) · 2024-05-01
- HighFDA Recalls Fluorescein Sodium Ophthalmic Strips for Manufacturing Defect
FDA (Drugs) · 2024-05-01
- HighOphthalmic Drug GloStrips Recalled for Active Ingredient Impurities
FDA (Drugs) · 2024-05-01
- LowNomax Recalls Fluorescein Sodium Ophthalmic Strips for Content Uniformity Issues
FDA (Drugs) · 2015-04-29
Same hazard · subpotent drug
See all →- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02